# Byline Bancorp, Inc.: financial statements, quarterly

BY · NYSE · CIK 1702750 · [Financials](/sectors/financials.md)

Pages: [Overview](/companies/by.md) · [Financials](/companies/by/financials.md) · [Filings](/companies/by/filings.md) · [Insiders](/companies/by/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/by/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [44.1](/filings/0000950170-23-058881.md) | [49.3 d](/filings/0000950170-24-024969.md) | [52.8](/filings/0000950170-24-052982.md) | [55.0](/filings/0000950170-24-090900.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [9.9](/filings/0000950170-24-120042.md) | [10.4 d](/filings/0001193125-26-083194.md) | [10.1](/filings/0000950170-25-062758.md) | [10.4](/filings/0000950170-25-105126.md) | [9.7](/filings/0001193125-25-272446.md) | [10.0 d](/filings/0001193125-26-083194.md) | [9.2](/filings/0001193125-26-201603.md) | [8.8](/filings/0001193125-26-337960.md) | [12.7](/filings/0001193125-25-272446.md) | [12.4 d](/filings/0001193125-26-083194.md) | [12.1](/filings/0001193125-26-201603.md) | [13.9](/filings/0001193125-26-337960.md) |
| Net income | $m | [28.2](/filings/0000950170-24-120042.md) | [29.6 d](/filings/0001193125-26-083194.md) | [30.4](/filings/0000950170-25-062758.md) | [29.7](/filings/0000950170-25-105126.md) | [30.3](/filings/0001193125-25-272446.md) | [30.3 d](/filings/0001193125-26-083194.md) | [28.2](/filings/0001193125-26-201603.md) | [30.1](/filings/0001193125-26-337960.md) | [37.2](/filings/0001193125-25-272446.md) | [34.5 d](/filings/0001193125-26-083194.md) | [37.6](/filings/0001193125-26-201603.md) | [40.2](/filings/0001193125-26-337960.md) |
| Diluted EPS | $ per share | [0.65](/filings/0000950170-24-120042.md) | not reported | [0.70](/filings/0000950170-25-062758.md) | [0.68](/filings/0000950170-25-105126.md) | [0.69](/filings/0001193125-25-272446.md) | not reported | [0.64](/filings/0001193125-26-201603.md) | [0.66](/filings/0001193125-26-337960.md) | [0.82](/filings/0001193125-25-272446.md) | not reported | [0.83](/filings/0001193125-26-201603.md) | [0.90](/filings/0001193125-26-337960.md) |
| Basic EPS | $ per share | [0.66](/filings/0000950170-24-120042.md) | not reported | [0.70](/filings/0000950170-25-062758.md) | [0.68](/filings/0000950170-25-105126.md) | [0.70](/filings/0001193125-25-272446.md) | not reported | [0.65](/filings/0001193125-26-201603.md) | [0.66](/filings/0001193125-26-337960.md) | [0.82](/filings/0001193125-25-272446.md) | not reported | [0.84](/filings/0001193125-26-201603.md) | [0.90](/filings/0001193125-26-337960.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [429](/filings/0000950170-23-058881.md) | [226](/filings/0000950170-25-030118.md) | [637](/filings/0000950170-24-052982.md) | [730](/filings/0000950170-24-090900.md) | [453](/filings/0000950170-24-120042.md) | [563](/filings/0001193125-26-083194.md) | [421](/filings/0000950170-25-062758.md) | [218](/filings/0000950170-25-105126.md) | [259](/filings/0001193125-25-272446.md) | [149](/filings/0001193125-26-337960.md) | [198](/filings/0001193125-26-201603.md) | [194](/filings/0001193125-26-337960.md) |
| Total assets | $m | [8,943](/filings/0000950170-23-058881.md) | [8,882](/filings/0000950170-25-030118.md) | [9,411](/filings/0000950170-24-052982.md) | [9,634](/filings/0000950170-24-090900.md) | [9,424](/filings/0000950170-24-120042.md) | [9,497](/filings/0001193125-26-083194.md) | [9,585](/filings/0000950170-25-062758.md) | [9,720](/filings/0000950170-25-105126.md) | [9,812](/filings/0001193125-25-272446.md) | [9,653](/filings/0001193125-26-337960.md) | [9,910](/filings/0001193125-26-201603.md) | [9,932](/filings/0001193125-26-337960.md) |
| Total liabilities | $m | [8,023](/filings/0000950170-23-058881.md) | [7,892](/filings/0000950170-25-030118.md) | [8,401](/filings/0000950170-24-052982.md) | [8,601](/filings/0000950170-24-090900.md) | [8,328](/filings/0000950170-24-120042.md) | [8,405](/filings/0001193125-26-083194.md) | [8,454](/filings/0000950170-25-062758.md) | [8,528](/filings/0000950170-25-105126.md) | [8,575](/filings/0001193125-25-272446.md) | [8,385](/filings/0001193125-26-337960.md) | [8,629](/filings/0001193125-26-201603.md) | [8,628](/filings/0001193125-26-337960.md) |
| Short-term borrowings | $m | [20.0](/filings/0000950170-23-058881.md) | [18.3](/filings/0000950170-25-030118.md) | [16.7](/filings/0000950170-24-052982.md) | [15.0](/filings/0000950170-24-090900.md) | [13.3](/filings/0000950170-24-120042.md) | [11.7](/filings/0001193125-26-083194.md) | [0.0](/filings/0000950170-25-062758.md) | [0.0](/filings/0000950170-25-105126.md) | [0.0](/filings/0001193125-25-272446.md) | [0.0](/filings/0001193125-26-083194.md) | not reported | not reported |
| Shareholders' equity | $m | [920](/filings/0000950170-24-120042.md) | [990](/filings/0001193125-26-083194.md) | [1,009](/filings/0000950170-25-105126.md) | [1,033](/filings/0001193125-25-272446.md) | [1,096](/filings/0001193125-25-272446.md) | [1,091](/filings/0001193125-26-337960.md) | [1,131](/filings/0001193125-26-337960.md) | [1,192](/filings/0001193125-26-337960.md) | [1,238](/filings/0001193125-25-272446.md) | [1,268](/filings/0001193125-26-337960.md) | [1,280](/filings/0001193125-26-337960.md) | [1,304](/filings/0001193125-26-337960.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [78.6 d](/filings/0000950170-24-120042.md) | [(5.0) d](/filings/0001193125-26-083194.md) | [62.3](/filings/0000950170-25-062758.md) | [40.1 d](/filings/0000950170-25-105126.md) | [19.8 d](/filings/0001193125-25-272446.md) | [52.9 d](/filings/0001193125-26-083194.md) | [27.8](/filings/0001193125-26-201603.md) | [16.5 d](/filings/0001193125-26-337960.md) | [37.3 d](/filings/0001193125-25-272446.md) | [58.6 d](/filings/0001193125-26-083194.md) | [54.6](/filings/0001193125-26-201603.md) | [14.2 d](/filings/0001193125-26-337960.md) |
| Capital expenditure | $m | [1.3 d](/filings/0000950170-24-120042.md) | [1.0 d](/filings/0001193125-26-083194.md) | [0.5](/filings/0000950170-25-062758.md) | [0.7 d](/filings/0000950170-25-105126.md) | [0.6 d](/filings/0001193125-25-272446.md) | [2.1 d](/filings/0001193125-26-083194.md) | [2.0](/filings/0001193125-26-201603.md) | [1.1 d](/filings/0001193125-26-337960.md) | [0.4 d](/filings/0001193125-25-272446.md) | [0.5 d](/filings/0001193125-26-083194.md) | [0.5](/filings/0001193125-26-201603.md) | [1.0 d](/filings/0001193125-26-337960.md) |
| Dividends paid | $m | [4.1 d](/filings/0000950170-24-120042.md) | [3.9 d](/filings/0001193125-26-083194.md) | [3.9](/filings/0000950170-25-062758.md) | [4.1 d](/filings/0000950170-25-105126.md) | [3.9 d](/filings/0001193125-25-272446.md) | [3.9 d](/filings/0001193125-26-083194.md) | [4.4](/filings/0001193125-26-201603.md) | [4.8 d](/filings/0001193125-26-337960.md) | [4.5 d](/filings/0001193125-25-272446.md) | [4.5 d](/filings/0001193125-26-083194.md) | [5.4](/filings/0001193125-26-201603.md) | [5.7 d](/filings/0001193125-26-337960.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-23-058881.md) | [0.0 d](/filings/0001193125-26-083194.md) | [0.0](/filings/0000950170-25-062758.md) | [0.0 d](/filings/0000950170-25-105126.md) | [0.0 d](/filings/0001193125-25-272446.md) | [0.0 d](/filings/0001193125-26-083194.md) | [0.7](/filings/0001193125-26-201603.md) | [13.1 d](/filings/0001193125-26-337960.md) | [0.2 d](/filings/0001193125-25-272446.md) | [9.8 d](/filings/0001193125-26-083194.md) | [9.8](/filings/0001193125-26-201603.md) | [9.1 d](/filings/0001193125-26-337960.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [37.4](/filings/0000950170-23-058881.md) | [37.5](/filings/0000950170-24-052982.md) | [37.3](/filings/0000950170-24-090900.md) | [43.5](/filings/0000950170-24-120042.md) | [43.7](/filings/0000950170-25-062758.md) | [43.7](/filings/0000950170-25-105126.md) | [44.0](/filings/0001193125-25-272446.md) | [44.3](/filings/0001193125-26-201603.md) | [45.5](/filings/0001193125-26-337960.md) | [45.4](/filings/0001193125-25-272446.md) | [45.0](/filings/0001193125-26-201603.md) | [44.8](/filings/0001193125-26-337960.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 45,186,420 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337960.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.